Table 1:
Test performance (MPX vs Elite) on routine donor samples in comparison to Procleix Ultrio Plus
| Measureable | cobas MPX | Ultrio Elite | Ultrio Plus |
|---|---|---|---|
| Number of samples run per system | 3638 | 3815 | 3790 |
| Specificity | 99.94% (CI 99.80%−99.99%) |
99.97% (CI 99.86%−100%) |
99.89% (CI 99.73%−99.97%) |
| Viral positive results detected in donors | |||
| HIV RNA reactive/anti-HIV reactive (HIV concordant) | 12 | 12 | 12 |
| HBV DNA reactive/HBsAg reactive (HBV concordant) | 7 | 7 | 7 |
| HCV RNA reactive/anti-HCV reactive (HCV concordant) | 1 | 1 | 1 |
| Total HBV DNA reactive/HBsAg negative (HBV Yields) | 6 of 7 | 4 of 7 | 0 of 7 |
| Donor 1 | HIV/HBV | HIV/HBV | HIV |
| Donor 2 | HIV/HBV | HIV/HBV | HIV |
| Donor 3 | HIV/HBV | HIV/HBV | HIV |
| Donor 4 | HIV/HBV | HIV only | HIV |
| Donor 5 | HIV only | HIV/HBV | HIV |
| Donor 6 | HBV | Not detected | Not detected |
| Donor 7 | HBV | Not detected | Not detected |